Your browser doesn't support javascript.
loading
The HDL particle composition determines its antitumor activity in pancreatic cancer.
Oberle, Raimund; Kührer, Kristina; Österreicher, Tamina; Weber, Florian; Steinbauer, Stefanie; Udonta, Florian; Wroblewski, Mark; Ben-Batalla, Isabel; Hassl, Ingrid; Körbelin, Jakob; Unseld, Matthias; Jauhiainen, Matti; Plochberger, Birgit; Röhrl, Clemens; Hengstschläger, Markus; Loges, Sonja; Stangl, Herbert.
Afiliación
  • Oberle R; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria raimund.oberle@meduniwien.ac.at.
  • Kührer K; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
  • Österreicher T; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
  • Weber F; School of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, Linz, Austria.
  • Steinbauer S; Center of Excellence Food Technology and Nutrition, University of Applied Sciences Upper Austria, Wels, Austria.
  • Udonta F; Department of Oncology, Hematology and Bone Marrow Transplantation, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wroblewski M; Department of Oncology, Hematology and Bone Marrow Transplantation, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ben-Batalla I; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hassl I; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
  • Körbelin J; ENDomics Lab, Department of Oncology, Hematology and Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Unseld M; Department of Medicine I, Division of Palliative Medicine, Medical University of Vienna, Vienna, Austria.
  • Jauhiainen M; Minerva Foundation Institute for Medical Research and Finnish Institute for Health and Welfare, Genomics and Biobank Unit, Biomedicum 2U, Helsinki, Finland.
  • Plochberger B; School of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, Linz, Austria.
  • Röhrl C; Center of Excellence Food Technology and Nutrition, University of Applied Sciences Upper Austria, Wels, Austria.
  • Hengstschläger M; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
  • Loges S; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Stangl H; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Life Sci Alliance ; 5(9)2022 09.
Article en En | MEDLINE | ID: mdl-35577388
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Life Sci Alliance Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Life Sci Alliance Año: 2022 Tipo del documento: Article País de afiliación: Austria